Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry
Authors
Keywords
-
Journal
Journal of Allergy and Clinical Immunology-In Practice
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-02-06
DOI
10.1016/j.jaip.2021.01.028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mepolizumab effectiveness and identification of super-responders in severe asthma
- (2020) Erin S. Harvey et al. EUROPEAN RESPIRATORY JOURNAL
- Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma
- (2020) Joanne E. Kavanagh et al. CHEST
- Real‐life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype
- (2020) Corrado Pelaia et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme
- (2020) Camille Taillé et al. EUROPEAN RESPIRATORY JOURNAL
- Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life
- (2020) Bruno Sposato et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Treatment Eligibility of Real-Life Mepolizumab-Treated Severe Asthma Patients
- (2020) Levi B. Richards et al. Journal of Allergy and Clinical Immunology-In Practice
- Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety
- (2020) David Price et al. European Respiratory Review
- Real-world mepolizumab in the prospective severe asthma REALITI-A study – initial analysis
- (2020) Tim Harrison et al. EUROPEAN RESPIRATORY JOURNAL
- Impact of mepolizumab on exacerbations in severe asthma: Results from a U.S. insurance claims data base
- (2020) Hector Ortega et al. ALLERGY AND ASTHMA PROCEEDINGS
- Cumulative dispensing of high oral corticosteroid doses for treating asthma in Australia
- (2020) Mark Hew et al. MEDICAL JOURNAL OF AUSTRALIA
- Patient Selection for Mepolizumab in Severe Asthma: Time for Reappraisal?
- (2020) Hannu Kankaanranta et al. Journal of Allergy and Clinical Immunology-In Practice
- Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study
- (2019) Dirkje S Postma et al. Lancet Respiratory Medicine
- Time to FOCUS on oral corticosteroid stewardship in asthma management
- (2019) Claire N. McBrien et al. RESPIROLOGY
- Mepolizumab improves small airway function in severe eosinophilic asthma
- (2019) Claude S. Farah et al. RESPIRATORY MEDICINE
- Management of Severe Asthma: a European Respiratory Society/American Thoracic Society Guideline
- (2019) Fernando Holguin et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy and safety of mepolizumab in a real-world cohort of patients with severe eosinophilic asthma
- (2019) Barak Pertzov et al. JOURNAL OF ASTHMA
- One year of mepolizumab. Efficacy and safety in real-life in Italy
- (2019) Diego Bagnasco et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response
- (2019) Marco Caminati et al. Expert Review of Respiratory Medicine
- Clinical Characterization and Predictors of IOS-Defined Small-Airway Dysfunction in Asthma
- (2019) Marcello Cottini et al. Journal of Allergy and Clinical Immunology-In Practice
- After asthma: redefining airways diseases
- (2018) Ian D Pavord et al. LANCET
- Pathophysiology of severe asthma: We’ve only just started
- (2018) Gregory G. King et al. RESPIROLOGY
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- Exacerbations of severe asthma
- (2012) V. M. McDonald et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- (2009) Pranabashis Haldar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
- (2009) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started